Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: skin, breast and colorectal cancers, and telehealth services
This report provides findings from an analysis of Medicare Benefits Schedule (MBS) for the months January 2020 to June 2020 to understand where changes in the number of cancer-related services have occurred, and the types of services affected during the COVID-19 pandemic. This analyses focuses...
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers
In this paper, experts in their fields provide perspectives on the current state of play and future directions for screening and surveillance for melanoma, Lynch syndrome, and liver, lung and prostate cancers in Australia.
Skin cancer in Australia provides comprehensive national information and statistics on skin cancer. It includes the latest available data and estimates to 2016, as well as trends over time. The report also describes risk factors, and presents a section on the limitations of non- melanoma...
Presents the number of new skin cancer problems managed per 100,000 encounters nationally and for each state and territory, from April 2008 to March 2013. Summary There is a paucity of Australian state-based data on the incidence of non-melanoma skin cancer (NMSC). Basal cell carcinoma...